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INTRODUCTION 
Vaccines are considered to be protective 
and they saved millions of people all over the 
world from life-threatening diseases.
1
 Most  
of the microorganisms i.e. pneumococci, 
rotavirus etc. kills millions of people but it is 
very difficult to control through old vaccines. 
However, few of them are in preparation and 
few of them reached to clinical trials or final 
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ABSTRACT 
Background and aims: The frequency of chronic hepatitis B virus infection varies 
totally in different part of the world but it could be categorized as high, intermediate and 
low endimicity. In this regard, development of safe and effective vaccines against 
infectious diseases especially hepatitis B virus that are still required for emerging new 
pathogens, re-emerging old pathogens and in order to improve the inadequate protection 
conferred by existing vaccines. In this study, immunological studies were conducted 
pertaining to investigate the aqueous leaves extract of Calotropis gigantea and Ficus 
religiosa for determining its adjuvant effect against hepatitis B vaccine containing 
surface antigen (HBsAg). 
Methods: In this study, our group evaluated the secondary metabolites that are present in 
the aqueous extract using high performance thin layer chromatography (HPTLC) and 
estimated its antibody (IgG) titre against HBsAg using variable doses (2.5-10 mg) of 
aqueous leaves extract of these medicinal plants and also determined splenocyte 
proliferation assay (ex vivo studies) on day 4 where mice (n=5) were immunized 
subcutaneously on day 0 with HBsAg (20 µg/ml, 100 µl). 
Results: The results showed that aqueous leaves extract showed anti-HBsAg titre and 
also enhanced splenocyte proliferation assay at higher doses (10 mg, 50 µl) as compared 
to control. 
Conclusion: Overall, the results showed that aqueous leaves extract of Calotropis 
gigantea and Ficus religiosa showed adjuvant activity against HBsAg. 
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stages of development.
2,3
 For vaccine 
preparation, major problems are generally 
reported i.e. instability of microbial  
genome, absence of adjuvants, lacking of 
experimentation related to animal model 
studies, and etc.
4,5
 In view of this, it is 
important to develop new adjuvants  
(plant based or synthetic) for vaccine antigen 
that are safe and economically viable. 
Development or screening of new adjuvants is 
highly required for vaccine antigen and 
eliminating various infectious diseases e.g. 
Hepatitis B virus (HBV).
6,7
 
Hepatitis B virus (HBV; Hepadnaviridae 
family) is classified into eight genotypes  
(i.e. A to H) based on sequence comparison 
and each genotype showed variation in 
geographical distribution. Out of three viral 
particles, HBsAg containing small spherical 
structures (20 nm diameter) and filaments 
(variable length, width 22 nm) where as host 
derived lipids without nucleic acids (viral) are 
considered to be non-infectious.
6,7
 In addition, 
HBV virion (infectious; double shelled 
structure; 42 nm in diameter) consisting of 
lipid envelope containing HBsAg that 
surrounds inner nucleocapsid composed of 
hepatitis B core antigen (HBcAg) complexed 
with virally encoded polymerase and the viral 
DNA genome.In contrast, detection of HBV 
disease has been the highest in 2015-16 when 
1,200 cases of the total 1.9 lakh samples tested 
were found to be positive. In comparison, only 
a 100 were found to be HIV positive (reported 
in Bowring and Lady Curzon Hospital, 
Bangalore; 14
th
 June 2016). 
In this regard, selection of proposed 
adjuvant candidates will likely be required  
to achieve protective immunity against 
vaccine antigen i.e. HBsAg. Number of 
immunologists claimed as well as reported 
that vaccine containing adjuvant (plant based 
or synthetic) that are capable of generating a 
broad immune response with high levels of 
antibodies production (IgG1 and IgG2a) and 
cytotoxic T lymphocytes that are responsible 
for eliminating intracellular infections.
6,7
 In 
view of this, there is an urgent need for 
eliminating this viral disease, lot of vaccines 
related to HBV that are available. In this 
study, we used HBV vaccine (Serum institute 
of India) containing HBsAg (20 µg) adsorbed 
on aluminium hydroxide (0.5 to 0.8 mg). In 
view of this, our group focused on those test 
candidates (i.e. medicinal plantsespecially 
Calotropis gigantea and Ficus religiosa will 
help us how to formulate the proposed 
adjuvant candidate (aqueous extract) extracted 
from Calotropis gigantea and Ficus religiosa 
in vaccines that are targeted specifically 
against viral infections. In view of this, these 
medicinal plants i.e. Calotropis gigantea and 
Ficus religiosa were selected because of 
immunopharmacological applications i.e. anti-
inflammatory, antioxidant, proteases etc.
8-11
 In 
the present study, our group evaluated the 
immunoadjuvant activity of these two 
medicinal plants against HBsAg. 
 
METHODS 
Assembled plant leaves of Calotropis 
gigantea and Ficus religiosa were collected 
from Vidya Pratishthan’s garden in the month 
of March 2016 and studied its immune 
adjuvant activity against HBsAg using these 
medicinal plant leaves macerated in liquid 
nitrogen and dissolved in phosphate buffered 
saline (PBS) in order to prepare aqueous 
extract. 
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For these studies, HPTLC analysis were 
performed and revealed the presence of 
secondary metabolites i.e. saponin, terpenoids, 
flavonoids and phenolics in the phytochemical 
profile of aqueous leaves extract of Calotropis 
gigantea and Ficus religiosa. The retardation 
factor (Rf) value of secondary metabolites in 
Calotropis gigantea (saponin, 0.31-0.46; 
terpenoid, 0.92; phenolics <0.72) where as 
Ficus religiosa (saponin, 0.37-0.79; terpenoid, 
0.96; phenolics, 1.14). 
For immune adjuvant activity, indirect 
Elisa was performed using standard HBsAg 
(1:1000 dilution) as coating antigen. Variable 
doses (2.5-10 mg) of aqueous leaves extract of 
Calotropis gigantea and Ficus religiosa were 
used and anti-HBsAg used as standard for the 
estimation of IgG antibody titre. Horse anti-
serum used as secondary antibody and optical 
density (OD) measured at 450 nm.
12
 
Ex vivo studies were carried out in mice 
model studies. Mice were immunized on day 
0 with HBsAg (20 µg/ml; 100 µl) and 
collected splenocytes on day 4 for 
proliferation assay and estimation of Th1 
(IFN-gamma and TNF alpha) cytokines from 
cell culture supernatant. These studies were 
conducted under ethical guidelines. 
Briefly, splenocytes (10
5
 cells/well;  
100 µl) were taken in 96 well plate for 48 h 
incubation in carbon dioxide incubator along 
with variable concentration of aqueous leaves 
extract (2.5-10 mg; 50 µl). Thereafter, further 
exposed with HBsAg (20 µg/ml; 10 µl) 
vaccinein a final volume of 0.2 ml. All these 
studies were conducted and analyzed at our 
institute between March to May 2016. After 
incubation, it was collected the supernatant 
after centrifuging these splenocytes samples 
containing HBsAg for estimation of Th1 
(IFN-gamma and TNF alpha) cytokines from 
cell culture supernatant. Finally, freshly added 
media in 96 well plate and then added MTT 
(2.5 mg/ml; 10 µl) solution. Incubate 96 well 
plate for another 3-4 h; centrifuging the plate, 
discarded the supernatant and formazon 
crystals settled at the bottom. These crystals 
were dissolved in dimethyl sulphoxide and the 
optical density was measured at 570 nm.
13,14
 
In addition, measurement of Th1 
cytokines (IFN-gamma and TNF alpha) 
production from splenocytes cell culture 
supernatant containing HBsAg of Calotropis 
gigantea and Ficus religiosa and this 
experiment was conducted using conventional 
ELISA kits and reagents, BD Biosciences, 
according to the manufacturer’s instructions.15 
The difference between control and 
treated groups of Calotropis gigantea and 
Ficus religiosa was determined by one way 
ANOVA test (using SPSS). 
 
 
RESULTS 
Elisa results confirmed that aqueous 
leaves extract showed anti-HBsAg titre at 
higher doses (10 mg) as shown in Figure 1. 
Anti-HBsAg culture supernatant of 
splenocytes used as standard for these studies 
and results showed enhancement of anti-
HBsAg titre as compared to control. 
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Figure 1: ELISA assay 
Indirect Elisa was performed using standard HBsAg (1:1000 dilution) as coating antigen. Aqueous leaves extract of 
Calotropis gigantea and Ficus religiosa, anti-HBsAg samples were used for the estimation of anti-HBsAg antibody 
titre. Horse anti-serum used as secondary antibody and optical density measured at 450 nm. The difference between 
the control and standard is determined by one way ANOVA test. 
 
The effect of aqueous leaves extract on 
splenocyte proliferation assay as shown in 
Figure 2. The results showed that aqueous 
leaves extract showed anti-HBsAg proliferation 
at higher doses (10 mg; 50 µl). Anti-HBsAg cell 
culture supernatant was used as standard for 
these studies and results showed enhancement of 
proliferation as compared to control. 
 
 
 
Figure 2: Splenocyte proliferation assay 
Spleen cells (106 cells/ml; 100 µl) were treated with variable doses of aqueous leaves extract in presence HBsAg (as 
already described in materials and methods section). Values are expressed in Mean ± S.E.The difference between 
the control and standard is determined by one way ANOVA test. 
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In this study, splenocyte cell culture 
supernatant containing HBsAg were 
collected for estimation of Th1 cytokines as 
shown in Figure 3. The results showed that 
aqueous leaves extract showed enhancement 
in Th1 cytokines at lower doses (0.625 mg) 
as compared to control and standard 
(HBsAg). 
 
A) IFN- gamma 
 
B) TNF alpha 
 
Figure 3: ELISA assay (Th1 cytokines) 
Spleen cells (106 cells/ml; 100 µl) were treated with variable doses of aqueous leaves extract in presence HBsAg 
and cell culture supernatant was collected for the estimation of cytokines (IFN-gamma and TNF alpha). Values are 
expressed in Mean ± S.E.The difference between the control and standard is determined by one way ANOVA test. 
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DISCUSSION 
Hepatitis B is highly endemic disease 
and is reported in various developing regions 
(with large population) i.e. South East Asia, 
China, sub-Saharan Africa, and etc. In these 
areas, more than 80 % of the population 
showed serological evidence of hepatitis  
B viral infection. Most of these infections  
are generally caused during infancy or 
childhood. Since most of these infections in 
children are asymptomatic but evidence is 
very less related to hepatitis B viral infection, 
but the rates of chronic liver disease or liver 
cancer are highly reported in adults. In this 
regard, our group focused on those medicinal 
plants that tried to reduce the burden of this 
disease i.e. hepatitis B. Lot of commercial 
vaccines that are available in the market but 
still trying to increase the immunogenicity of 
this vaccine antigen. In other words, 
medicinal plant products were considered and 
proved as alternative sources of vaccine 
adjuvants against specific protein antigens 
e.g. HBsAg. Lot of research work is done 
related to plant based adjuvants for vaccine 
production. Most of the commercial vaccines 
containing adjuvant i.e. alum that are 
available and administered subcutaneously, 
intraperitoneally, intradermal, and etc. which 
have the capability to enhance antibody 
response. Alum is one of the approved 
adjuvant for human use that elicits only 
humeral antibody (Th2) response and poorly 
elicited cell mediated (Th1) immunity. In an 
effort to screen those molecules or test 
adjuvant candidates extracted from medicinal 
plants that enhanced antibody profile (IgG) 
and cell mediated (T cell derived cytokines 
i.e. IFN-gamma and TNF alpha) immune 
response against vaccine antigen (HBsAg).
6,7
 
For these studies, indirect Elisa was 
performed using HBsAgas coating antigen 
andtestedvariable doses of aqueous leaves 
extract of Calotropis gigantea and Ficus 
religiosa and showed anti-HBsAg titre. For 
further confirmation of its immunoadjuvant 
activity tested in mice model studies using  
ex vivo studies and performed splenocyte 
proliferation assay. 
In animal model studies, mice were 
immunized with HBsAg intraperitoneally on 
day 0 and collect the splenocytes on day 4 
and were further exposed to HBsAg in the 
presence of aqueous leaves extract of these 
two medicinal plants and showeddose 
dependent change (enhancement at lower 
doses) in the proliferation as compared to 
HBsAg and control. In addition, HBsAg was 
recognized strongly by aqueous leaves 
extract containing primary as well as 
secondary metabolites and antibody-secreting 
cells from vaccines. Studying this interaction 
will allow us to further elucidate the 
effectiveness of antigen adjuvant 
combinations. For its isolation, extraction as 
well as purification of adjuvants from various 
medicinal plants were considered to be safe 
and totally free from animal or human 
pathogens, and also provided some beneficial 
effects in terms of cost, distribution and 
production. 
As per the literature which reveals that 
Th1 cytokines (IFN-gamma and TNF 
alpha) are the indicators of cell mediated 
immunity.
6,7
 In this study, we evaluated 
immunoadjuvant activity of aqueous extract 
and can be determined through cytokines 
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from splenocyte cell culture supernatant 
whether these aqueous extract showed 
stimulatory or suppressive effect. The 
results showed that aqueous extract showed 
enhancement in Th1 cytokines at lower 
doses as compared to HBsAg and 
control.Overall, the results showed that 
aqueous leaves extract of Calotropis 
gigantea and Ficus religiosa showed 
vaccine adjuvant potential, but it’s urgently 
needed some preservatives to store for long 
time in clinical trial studies. 
The potencyrate of routine infant 
hepatitis B immunization is significantly 
reduced or inhibiting the prevalence of 
chronic hepatitis B viral infection has been 
reported in number of countries. However, 
there are still many challenges or approaches 
to achieve the goal of universal childhood 
immunization against these infectious 
diseases especially hepatitis B, such as 
imperfect immunization delivery 
infrastructure, low coverage and lack of 
financial sustainability. Therefore, to 
continue to promote access to hepatitis B 
vaccines worldwide, great efforts are needed 
to support countries to ensure sustained 
funding for immunization programs. 
Additionally, because the current vaccine 
must be given by injection, the development 
of an effective and safe oral HBV vaccine 
would be advantageous. 
 
CONCLUSION 
Medicinal plants i.e. Calotropis 
gigantea and Ficus religiosa were selected 
because of number of immune 
pharmacological studies as well as their 
integral role in cellular and humoral 
immunity. These findings about these 
proposed adjuvants can also be used to 
formulate with other vaccine antigens. 
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